Artificial Intelligence

Artificial intelligence (AI) is transforming how we make decisions in highly complex environments — and in the Neonatal ICU, this represents a real possibility of saving brains and futures. At PBSF, we develop AI-based solutions that act as an additional layer of clinical surveillance, supporting professionals in the early recognition of changes that might go unnoticed in the daily routine of the ICU.

Our AI is trained to continuously analyze data collected by sensors and monitors connected to the babies. From this analysis, the algorithms identify patterns that precede neurological, respiratory, or hemodynamic deteriorations. One of the most significant advancements is the ability to generate risk alerts for seizures up to 8 hours in advance, providing the medical team with a valuable time window to intervene.

In addition to analyzing physiological signals, PBSF also applies AI in video image interpretation, contributing to real-time diagnostics even in locations with limited access to specialists. This technology is being used to support the neurological assessment of newborns in remote ICUs, expanding the reach and equity of care.

Our goal is not to replace clinical judgment but to enhance it. AI acts as a decision-support tool, reducing uncertainties, accelerating responses, and strengthening precision in critical moments. With this, we directly contribute to the prevention of avoidable neurological sequelae and to faster, safer care.

At PBSF, artificial intelligence is not just a technological innovation — it is a purpose-driven tool. It serves life, is integrated into clinical practice, and aligns with our mission to protect brains and save futures from the very first days.

To learn more about our artificial intelligence algorithms, contact our commercial team.